Mortality News and Research

RSS

Postpartum women's experience of social restrictions during COVID-19

A new study published on the medRxiv* preprint server has focused on the effect of various social restrictions or lack of social support on women who delivered and raised babies during the pandemic.

27 Oct 2021

Cholesterol-lowering drugs not helpful in reducing COVID-related mortality or severity

In the worldwide effort to battle SARS-CoV-2, the virus that causes COVID-19, researchers have often turned to medications used as therapies for other conditions in the hopes of finding ones that either kill the coronavirus or lessen the impacts from its infection.

26 Oct 2021

UTSA research could be key to decreasing maternal mortality rates in the U.S.

Researchers from The University of Texas at San Antonio College for Health, Community and Policy (HCaP) have conducted a study that could be key to decreasing maternal mortality rates in the U.S.

26 Oct 2021

Clinically significant cataract associated with greater mortality risk from vascular causes

Clinically significant cataract is associated with an increased risk of death from vascular causes, such as stroke and heart attack, suggests research published online in the British Journal of Ophthalmology.

26 Oct 2021

Non-pharmaceutical interventions reduce likelihood of SARS-CoV-2 infection following high-risk exposure

Researchers have been investigating the efficacy of many of the non-pharmaceutical interventions applied and exploring the theory that mask use results in less severe symptoms in individuals infected with SARS-COV-2.

26 Oct 2021

Mapping C. difficile: Advanced ribotyping technology helps researchers keep track of deadly disease

Interview with Seth Walk, Principal Investigator and Associate Professor, Department of Microbiology and Cell Biology, Montana State University

From Promega Corporation 26 Oct 2021

UQ-developed oral vaccine marks a leap forward in the battle against hookworm infections

There's been a significant breakthrough in the development of a vaccine to prevent hookworm infection – a parasite which causes serious disease in tens of millions of people globally.

26 Oct 2021

Sexually dimorphic placental antibody transfer during SARS-CoV-2 infection

In a paper recently published in the journal Science Translational Medicine by Bordt et al. (October 19th, 2021), maternal SARS-CoV-2 infections are studied with particular regard to maternal-fetal antibody transfer and virus-induced placental interferon responses, finding a sexually dimorphic response that results in lesser antibody transfer to the male fetus.

26 Oct 2021

Water and surface surveillance can detect 93% of school-based COVID-19 cases

A new study posted to the medRxiv* preprint server explores environmental surveillance of elementary school settings for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through wastewater and surface samples monitoring. The researchers demonstrated that 93% of the COVID-19 cases in public elementary schools could be identified using this method.

25 Oct 2021

COVID-19's impact on excess mortality in 2020 varied widely across Europe

A team of researchers has demonstrated that the impact of the coronavirus disease 2019 (COVID-19) pandemic on excess mortality varied widely both between and within five European countries in 2020.

25 Oct 2021

Development of light-based tool for the inactivation of SARS-CoV-2

Researchers from EMIT bio have developed a biological light unit that can sterilize surfaces, killing SARS-CoV-2.

25 Oct 2021

Study finds lower non-COVID-19 death rates in COVID-19 vaccine recipients

COVID-19 vaccine recipients had lower non-COVID-19 death rates than people who weren't vaccinated, according to Kaiser Permanente research published [publication date] in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

25 Oct 2021

Antidepressant offers no improvement in agitation for people with dementia, study shows

A drug used to treat agitation in people with dementia is no more effective than a placebo, and might even increase mortality, according to a new study.

22 Oct 2021

Study examines effectiveness of BNT162b2 vaccine against Delta variant in adolescents

The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the effectiveness of the Pfizer/BioNTech BNT162B2 vaccine against the Delta variant of SARS-CoV-2 among adolescents.

22 Oct 2021

Health and climate change in Australia

The 2021 MJA–Lancet Countdown report represents a collaborative effort between University College London, and seven Australian institutions, mediated by The Lancet in partnership with The Medical Journal of Australia.

22 Oct 2021

Replication of SARS-CoV-2 variants in different cell and organ models

In this study, the replication of B.1.1.7 viruses was analyzed in different cell and organ models and dwarf hamsters.

22 Oct 2021

Development of a safe and effective COVID-19 nanoparticle vaccine

Researchers from ReVacc scientific have attempted to demonstrate the effectiveness of a new vaccine, REVC-128, two weeks post-administration.

22 Oct 2021

Vaccinating adolescents may reduce the impact of COVID-19, according to a UK modeling study

A recent study from the United Kingdom, published in the open-access journal Vaccines, implies that vaccinating adolescents and children may be pivotal in reducing infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as ensuing coronavirus disease (COVID-19) morbidity and mortality across all age groups.

21 Oct 2021

Investigational inhaled COVID-19 treatment graduates to phase 3 in ACTIV-2 trial

The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that the external data and safety monitoring board (DSMB) has recommended that SNG001, an inhaled formulation of interferon beta, advance to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).

21 Oct 2021

Targeted drug shows promising activity in kidney cancer patients with brain metastases

A targeted drug has shown promising activity against brain metastases resulting from kidney cancer, achieving a 50 percent response rate, and supporting further studies of the drug in this patient group whose poor prognosis has created a significant unmet need.

21 Oct 2021

Mortality News and Research

Postpartum women's experience of social restrictions during COVID-19

Cholesterol-lowering drugs not helpful in reducing COVID-related mortality or severity

UTSA research could be key to decreasing maternal mortality rates in the U.S.

Clinically significant cataract associated with greater mortality risk from vascular causes

Non-pharmaceutical interventions reduce likelihood of SARS-CoV-2 infection following high-risk exposure

Mapping C. difficile: Advanced ribotyping technology helps researchers keep track of deadly disease

UQ-developed oral vaccine marks a leap forward in the battle against hookworm infections

Sexually dimorphic placental antibody transfer during SARS-CoV-2 infection

Water and surface surveillance can detect 93% of school-based COVID-19 cases

COVID-19's impact on excess mortality in 2020 varied widely across Europe

Development of light-based tool for the inactivation of SARS-CoV-2

Study finds lower non-COVID-19 death rates in COVID-19 vaccine recipients

Antidepressant offers no improvement in agitation for people with dementia, study shows

Study examines effectiveness of BNT162b2 vaccine against Delta variant in adolescents

Health and climate change in Australia

Replication of SARS-CoV-2 variants in different cell and organ models

Development of a safe and effective COVID-19 nanoparticle vaccine

Vaccinating adolescents may reduce the impact of COVID-19, according to a UK modeling study

Investigational inhaled COVID-19 treatment graduates to phase 3 in ACTIV-2 trial

Targeted drug shows promising activity in kidney cancer patients with brain metastases

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News